Concepedia

Joseph Merchant

JM

3

Publications

142

Citations

3

H-Index

2000

Active since

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

Joseph Merchant is an author at University of Wisconsin Carbone Cancer Center specializing in cancer therapeutics, medicine, and pharmacology.

Top concepts

Publications per year

2000–2019

3

Publications

3

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

, , +9

Pilot and Safety Trial of Carboplatin, Paclitaxel, and Thalidomide in Advanced Non–Small-Cell Lung Cancer

Joseph Merchant, KyungMann Kim, Minesh P. Mehta et al. · Clinical Lung Cancer · 2000 · 37 citations

, , +7

Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.

Joseph Merchant, Kendra D. Tutsch, Amy Dresen et al. · PubMed · 2002 · 20 citations

Rows per page

1–3 of 3